VistaGen Therapeutics Inc
NASDAQ:VTGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VistaGen Therapeutics Inc
NASDAQ:VTGN
|
US |
|
N
|
NOW Inc
BMV:DNOW
|
US |
|
J
|
JPMorgan Chase & Co
BMV:JPM
|
US |
|
Deutsche Lufthansa AG
OTC:DLAKY
|
DE |
|
M
|
Mitsubishi Chemical Holdings Corp
F:M3C
|
JP |
Wall St Price Targets
VTGN Price Targets Summary
VistaGen Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for VTGN is 3.7995 USD with a low forecast of 0.909 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VTGN's stock price target?
Price Target
3.7995
USD
According to Wall Street analysts, the average 1-year price target for VTGN is 3.7995 USD with a low forecast of 0.909 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for VistaGen Therapeutics Inc?
Projected CAGR
183%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 183%.